CorMedix
(NASDAQ) CRMD
CorMedix Financials at a Glance
Market Cap
$613.49M
Revenue (TTM)
$400.05M
Net Income (TTM)
$181.01M
EPS (TTM)
$2.10
P/E Ratio
3.73
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$7.93
Volume
546,802.496
Open
$7.90
Price
$7.93
Volume
546,802.496
Open
$7.90
Previous Close
$7.82
Daily Range
$7.64 - $7.95
52-Week Range
$6.13 - $17.43
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$7.93
Volume
546,802.496
Open
$7.90
Previous Close
$7.82
Daily Range
$7.64 - $7.95
52-Week Range
$6.13 - $17.43
CRMD News
CRMD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CorMedix
Industry
Pharmaceuticals
Sector
Health CareEmployees
191
CEO
Joseph Todisco, MBA
Website
www.cormedix.comHeadquarters
Berkeley Heights, NJ 07922, US
CRMD Financials
Key Financial Metrics (TTM)
Gross Margin
86%
Operating Margin
48%
Net Income Margin
45%
Return on Equity
66%
Return on Capital
28%
Return on Assets
22%
Earnings Yield
26.81%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$613.49M
Shares Outstanding
78.45M
Volume
546.80K
Avg. Volume
1.36M
Financials (TTM)
Gross Profit
$275.75M
Operating Income
$150.14M
EBITDA
$165.13M
Operating Cash Flow
$175.05M
Capital Expenditure
$2.26M
Free Cash Flow
$172.79M
Cash & ST Invst.
$149.52M
Total Debt
$148.91M
CorMedix Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$127.43M
+226.1%
Gross Profit
$105.12M
+180.4%
Gross Margin
82.50%
N/A
Market Cap
$613.49M
N/A
Market Cap/Employee
$9.59M
N/A
Employees
64
N/A
Net Income
$38.60M
+87.0%
EBITDA
$74.20M
+256.5%
Quarterly Fundamentals
Net Cash
$33.20M
-56.9%
Accounts Receivable
$154.81M
+183.5%
Inventory
$30.73M
+310.4%
Long Term Debt
$144.88M
+47545.1%
Short Term Debt
$0.00
-100.0%
Return on Assets
22.19%
N/A
Return on Invested Capital
28.20%
N/A
Free Cash Flow
$41.65M
+111.2%
Operating Cash Flow
$42.38M
+114.7%